| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 409.1 | 395.5 | 281.6 |
| Other income | 10.6 | 6.7 | 15.7 |
| Total income | 419.7 | 402.3 | 297.3 |
| Profit before exceptional items & tax | -42.7 | -42.7 | -14.0 |
| Profit before tax | -40.9 | -39.8 | -12.0 |
| Net profit | -52.4 | -53.2 | -20.6 |
| Operating margin | -9.7% | -9.9% | -4.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +45.30% |
|---|---|
| Operating profit, year on year | -79.50% |
| Operating profit, quarter on quarter | -7.90% |
NSE results filing, NSE: AEQUS. Figures extracted from the filing.
Aequs Ltd: key numbers
- Share price
- ₹211.95
- Market cap
- ₹14,215 Cr
- Revenue (annual)
- ₹1,230 Cr
- Net profit (annual)
- ₹-113.2 Cr
- P/E (TTM)
- -70.4×Sector 52.2×
- Promoter holding
- 59.09%+0.00% QoQ
- FII holding
- 5.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aequs Ltd
All →Aequs Other Announcement
Aequs filed CARE Ratings' quarterly monitoring report on its IPO proceeds for the quarter ended September 2026. The report found no deviation from the stated objects.
Aequs Earnings Call Transcript: Key Takeaways
Aerospace's strong 44% growth is being overshadowed by execution delays and inventory write-downs in the consumer business.
- Call
- Guides 400% growth
Aequs Employee Stock Options
Aequs Limited's NRC granted 2,00,000 employee stock options under its ESOP 2025 plan at an exercise price of ₹235.50. The grant is an employee incentive step, with no cash raised by the company.
- Execution
- Options vest over a minimum of 1 year and are exercisable within 3 years of vesting
Aequs Results Update
Aequs Q2 FY27 revenue rose 45% YoY, but EBITDA fell 45% and losses widened. Consumer ramp slowed, while ₹6,500 Mn promoter warrants fund expansion.
Aequs Investor Presentation: Key Takeaways
H1 FY27 revenue ₹8,046 Mn (+50% YoY); EBITDA ₹460 Mn (6% margin); PAT loss ₹(1,054) Mn as Consumer ramp costs hit.
Aequs Convertible Warrants
Aequs shareholders approved preferential warrants to promoter trust Mellwood at the October 22, 2026 EGM. Votes in favour were 98.68%.